Farnesyl anthranilate suppresses the growth, in vitro and in vivo, of murine B16 melanomas

被引:19
作者
Mo, H
Tatman, D
Jung, M
Elson, CE
机构
[1] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA
[2] Univ Munster, Inst Pharmazeut Chem, D-48149 Munster, Germany
关键词
isoprenoids; farnesol; B16; melanomas; diet; apoptosis; G1; arrest;
D O I
10.1016/S0304-3835(00)00490-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The numbers of isoprene residues and unsaturated bonds, cis/trans configuration, and head group polarity influence the tumor-suppressive potency of acyclic isoprenoid hydrocarbons and alcohols: within the series tested, trans, trans farnesol had the greatest potency. Geraniol esters had increased potency relative to that of the free alcohol. Farnesyl anthranilate induced a concentration-dependent decrease in the B16 melanoma cell population, in part due to an increased proportion of cells in the G1 phase of the cell cycle and in part by the increased the proportion of apoptotic cells. Farnesyl anthranilate (1.5 mmol/kg diet) significantly suppressed the growth of implanted B16 melanomas and lowered the plasma cholesterol levels of tumor-free mice. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 47 条
[31]   HYPOCHOLESTEROLEMIC ACTIVITY OF SYNTHETIC AND NATURAL TOCOTRIENOLS [J].
PEARCE, BC ;
PARKER, RA ;
DEASON, ME ;
QURESHI, AA ;
WRIGHT, JJK .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) :3595-3606
[32]  
POTTER VR, 1958, FED PROC, V17, P691
[33]   Dietary alpha-tocopherol attenuates the impact of gamma-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in chickens [J].
Qureshi, AA ;
Pearce, BC ;
Nor, RM ;
Gapor, A ;
Peterson, DM ;
Elson, CE .
JOURNAL OF NUTRITION, 1996, 126 (02) :389-394
[34]  
SHOFF SM, 1991, CANCER RES, V51, P37
[35]   DEFECTIVE MACROMOLECULE BIOSYNTHESIS AND CELL-CYCLE PROGRESSION IN A MAMMALIAN-CELL STARVED FOR MEVALONATE [J].
SINENSKY, M ;
LOGEL, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (10) :3257-3261
[36]  
SIPERSTEIN MD, 1964, CANCER RES, V24, P1108
[37]   MECHANISMS OF APOPTOSIS - INTEGRATION OF GENETIC, BIOCHEMICAL, AND CELLULAR INDICATORS [J].
STEWART, BW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) :1286-1296
[38]  
Thibault A, 1996, CLIN CANCER RES, V2, P483
[39]  
Ura H, 1998, MOL CARCINOGEN, V21, P93, DOI 10.1002/(SICI)1098-2744(199802)21:2<93::AID-MC3>3.0.CO
[40]  
2-P